Every 10-Q that Kaival Brnds Innovatns Grp Inc (KAVL) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow KAVL and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full KAVL filings page.
Kaival Brands Innovations Group reports another weak quarter with a small revenue base and ongoing losses. For the quarter ended April 30, 2026, revenue was about $37,000, almost entirely from royalties under its international licensing agreement with Philip Morris Products, down from roughly $47,000 a year earlier. The company recorded a net loss of about $575,000 for the quarter and $1.2 million for the first six months, though both losses narrowed sharply versus the prior year as operating expenses fell from prior elevated levels.
Cash was $278,000 and management disclosed a working capital deficit and substantial doubt about the company’s ability to continue as a going concern without new funding. Kaival no longer earns revenue from U.S. BIDI Stick distribution because of FDA marketing denial orders and an International Trade Commission patent case, leaving it heavily reliant on Philip Morris royalties and potential monetization of GoFire intellectual property. The company also holds significant outstanding stock options and warrants, which could dilute shareholders if exercised.
Kaival Brands Innovations Group, Inc. reported a net loss of $620,787 for the quarter ended January 31, 2026, compared with a loss of $4,061,080 a year earlier. Quarterly revenue was $92,938, down from $202,603, and now comes entirely from royalty income under its Philip Morris international licensing agreement.
Cash increased to $797,500 and working capital to $497,068, helped by $1,015,443 of common share issuance, but operations used $752,349 of cash. The company has ceased Bidi Stick distribution in the U.S. following FDA marketing denial orders and an ITC patent case, and explicitly warns of substantial doubt about its ability to continue as a going concern without additional capital.
Kaival Brands Innovations Group, Inc. (KAVL) filed a 10-Q for the quarter ended July 31, 2025 that highlights material legal, regulatory and liquidity risks. The company discloses substantial reliance on royalty revenue from a PMI licensing agreement and concentration of product sales: $1,228,535 from QuikTrip, $990,589 (19%) from GPM and $575,183 (11%) from FAVS. Management reports an accumulated deficit (presented as approximately $6.62 million) and intangible assets of $11.80 million with amortization expense of $589,806 for the nine months. The filing warns of significant doubt about the company’s ability to continue as a going concern due to the need for additional financing and regulatory uncertainty, including an FDA marketing denial order for Classic BIDI Stick upheld by the 11th Circuit and an ITC patent infringement investigation. Cash on hand included uninsured deposits of $1,018,926. The company paid $405,000 in Series B dividends on December 3, 2024 and recognized $2,873,750 of stock compensation expense in the nine months ended July 31, 2025.